Arcus Biosciences

RCUSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.644 B

$28.62 +1.02%

Close of 7 Aug 2026

Revenue

$247.0M

#2224 by revenue

Earnings

-$353.0M

Loss-making

Shares outstanding

127,333,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#71Structure TherapeuticsGPCR$3.78B
#72Aktis OncologyAKTS$3.73B
#73Arcus BiosciencesRCUS$3.64B
#74IDEAYA BiosciencesIDYA$3.57B
#75Organon & Co.OGN$3.57B

Where these numbers come from

Share counts and financials for Arcus Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.